Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

Clinical trial NCT07499128 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07499128
Sponsor: National Cancer Institute (NCI)
Status: ENROLLING_BY_INVITATION
Phase: Not Applicable
Study type: INTERVENTIONAL

Cytokine Release Syndrome Neoplasms Lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Multiple Myeloma Lymphoma Mantle-cell Immunotherapy Cell and Tissue-Based Therapy Cytokines Monitoring Physiologic Immune Monitoring Wearable Electronic Devices

Start date: 2026-05-27
Primary completion: 2029-06-30
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.